跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,308 条关于
“Inflammasome ASC Inhibitor IC 100”
全部
40,308
临床试验
18,412
药物
8,928
机构
267
资讯
12,701
去年
ZyVersa Highlights Data on Inflammasome Inhibition for Type 2 Diabetes Prevention
去年
ZyVersa Therapeutics to Present Kidney Disease Drug VAR 200 at JPM Healthcare Conference 2025
去年
ZyVersa's IC 100 Shows Promise as Disease-Modifying Treatment for Parkinson's Disease
去年
ZyVersa Therapeutics Initiates Phase 2a Trial for First-in-Class Diabetic Kidney Disease Treatment VAR 200
5年前
Novel NLRP3 Inflammasome Inhibitors Show Promise for Treating Multiple Inflammatory Diseases
去年
Emerging Therapies Show Promise for Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
去年
Halia Therapeutics Completes Enrollment in Phase 2a Trial of Novel NLRP3 Inflammasome Inhibitor for Myelodysplastic Syndrome
去年
NLRP3 Inflammasome Inhibition May Prevent Melanoma Hyper-Progression During Immunotherapy
2年前
Incendia Therapeutics Initiates Phase Ic Trial of PRTH-101 for Advanced Solid Tumors
去年
Error parsing response
第 1 页，共 1271 页
上一页
下一页
